| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
1-Methyl-1-[4-(4-trifluoromethoxy-phenyl)-1H-imidazol-2-yl]-ethylamine manufacturers
- PF-04885614
-
- $58.00
-
2026-05-11
- CAS:1480833-70-2
- Purity: 98.02%
- Supply Ability: 10g
- PF-04885614
-
- $58.00
-
2026-04-27
- CAS:1480833-70-2
- Purity: 98.02%
- Supply Ability: 10g
|
| | 1-Methyl-1-[4-(4-trifluoromethoxy-phenyl)-1H-imidazol-2-yl]-ethylamine Basic information |
| Product Name: | 1-Methyl-1-[4-(4-trifluoromethoxy-phenyl)-1H-imidazol-2-yl]-ethylamine | | Synonyms: | 1-Methyl-1-[4-(4-trifluoromethoxy-phenyl)-1H-imidazol-2-yl]-ethylamine;PF-04885614;2-(4-(4-(Trifluoromethoxy)phenyl)-1H-imidazol-2-yl)propan-2-amine;PF04885614,neurodevelopmental,neurological,PF-04885614,ion,Inhibitor,inhibit,Na+ channels,Sodium Channel,channel,PF 04885614,diseases,Na channels;1H-Imidazole-2-methanamine, α,α-dimethyl-5-[4-(trifluoromethoxy)phenyl]-;PF-04885614, 10 mM in DMSO | | CAS: | 1480833-70-2 | | MF: | C13H14F3N3O | | MW: | 285.2649696 | | EINECS: | | | Product Categories: | | | Mol File: | 1480833-70-2.mol | ![1-Methyl-1-[4-(4-trifluoromethoxy-phenyl)-1H-imidazol-2-yl]-ethylamine Structure](CAS/20180703/GIF/1480833-70-2.gif) |
| | 1-Methyl-1-[4-(4-trifluoromethoxy-phenyl)-1H-imidazol-2-yl]-ethylamine Chemical Properties |
| Boiling point | 414.6±45.0 °C(Predicted) | | density | 1.293±0.06 g/cm3(Predicted) | | storage temp. | room temp | | solubility | <28.53mg/ml in DMSO; <28.53mg/ml in ethanol | | form | Solid | | pka | 13.83±0.10(Predicted) | | color | Off-white to light yellow |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26 | | WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 |
| | 1-Methyl-1-[4-(4-trifluoromethoxy-phenyl)-1H-imidazol-2-yl]-ethylamine Usage And Synthesis |
| Uses | PF-04885614 is a potent NaV1.8 inhibitor, extracted from patent US2018328915. PF-04885614 has potential for neurological and neurodevelopmental diseases treatment[1]. | | Biological Activity | PF-04885614 is a potent and selective Nav1.8 inhibitor. | | storage | Store at +4°C | | References | [1] Brady MAHER, et al. Treatment of Neurological and Neurodevelopmental Diseases and Disorders Associated with Aberrant Ion Channel Expression and Activity. US20180328915A1. |
| | 1-Methyl-1-[4-(4-trifluoromethoxy-phenyl)-1H-imidazol-2-yl]-ethylamine Preparation Products And Raw materials |
|